General Information of the Compound
| Compound ID |
CP0055840
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,9,12,14-heptaene
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-Chlor-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepin
2-Chloro-11-(1-piperazinyl)-dibenz[b,f][1,4]oxazepine
2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine
2-Chloro-11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine
2-chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine
2-chloro-11-piperazin-1-yldibenzo[b,f][1,4]oxazepine
8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine
A-129
Amoxan
Amoxapina
Amoxapina [INN-Spanish]
Amoxapine
Amoxapine (JP15/USP/INN)
Amoxapine [USAN:BAN:INN:JAN]
Amoxapinum
Amoxapinum [INN-Latin]
Amoxepine
Ascendin
Asendin
Asendin (TN)
Asendis
Asendis (TN)
CL 67772
CL-67,772
CL-67772
Defanyl
Defanyl (TN)
Demolox
Demolox (TN)
Desmethylloxapin
Desmethylloxapine
KS-1197
Moxadil
Moxadil (TN)
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H16ClN3O
|
||||||||||||||||||
| Molecular Weight |
313.788
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
QWGDMFLQWFTERH-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
14028-44-5
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT00817, Cytochrome P450 2D6
Protein ID: PT01161, D(4) dopamine receptor
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Protein ID: PT02031, Voltage-dependent N-type calcium channel subunit alpha-1B
Clinical Information about the Compound